Gamma secretase inhibitors (GSIs) are compounds designed to inhibit the activity of the gamma secretase complex. These inhibitors are primarily researched for their potential therapeutic applications in neurodegenerative diseases like Alzheimer's Disease and certain types of cancer. By blocking the cleavage of APP, GSIs aim to reduce the production of amyloid-beta peptides, thereby addressing one of the pathological hallmarks of Alzheimer's Disease.
